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Abstract
Background: The inappropriate use of antimicrobials drives antimicrobial resistance. We conducted a study to map
physician decision-making processes for acute infection management in secondary care to identify potential targets
for quality improvement interventions.
Methods: Physicians newly qualified to consultant level participated in semi-structured interviews. Interviews were
audio recorded and transcribed verbatim for analysis using NVIVO11.0 software. Grounded theory methodology was
applied. Analytical categories were created using constant comparison approach to the data and participants were
recruited to the study until thematic saturation was reached.
Results: Twenty physicians were interviewed. The decision pathway for the management of acute infections
follows a Bayesian-like step-wise approach, with information processed and systematically added to prior
assumptions to guide management. The main emerging themes identified as determinants of the decision-making
of individual physicians were (1) perceptions of providing ‘optimal’ care for the patient with infection by providing
rapid and often intravenous therapy; (2) perceptions that stopping/de-escalating therapy was a senior doctor
decision with junior trainees not expected to contribute; and (3) expectation of interactions with local guidelines
and microbiology service advice. Feedback on review of junior doctor prescribing decisions was often lacking,
causing frustration and confusion on appropriate practice within this cohort.
Conclusion: Interventions to improve infection management must incorporate mechanisms to promote distribution
of responsibility for decisions made. The disparity between expectations of prescribers to start but not review/stop
therapy must be urgently addressed with mechanisms to improve communication and feedback to junior prescribers
to facilitate their continued development as prudent antimicrobial prescribers.
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Background
The growing threat of antimicrobial resistance (AMR) is
a leading patient health and safety issue, with estimates
that AMR will be responsible for more than 10 million
deaths by 2050 [1]. A major driver of AMR has been the
misuse of antimicrobials in humans [2]. Whilst reasons
for the misuse of antimicrobials in humans are complex
and multifaceted, a number of factors have been de-
scribed and investigated. At the individual level, pre-
scribers often prioritise the management of the patient
in front of them, paying little regard to the long-term
consequences (on future patients and generations) of
overusing antimicrobials [3]. Moreover, the majority of
antimicrobial prescribing is performed by individuals who
are not experts in infection management and may have lim-
ited understanding of antimicrobials and AMR [2, 4–6]. At
the hospital/team level a number of barriers to the effective
use of antimicrobials have been described, including the role
of team hierarchies and prescribing etiquette, which can
often hinder external interventions to optimise prescribing
behaviours [7–9]. Finally, the role of patient involvement in
the decision-making process for antimicrobial prescribing is
now recognised to also shape the decisions made by physi-
cians, with patient expectations and understanding of anti-
microbials being important in shaping the appropriate use
of therapy during infection management [10–12].
To address the challenges posed by AMR, the import-
ance of behaviour change interventions in improving the
long-term use of antimicrobials in infection management
has been recognised [8, 9, 13]. Despite the growing body
of evidence describing knowledge, attitudes and cultural
determinants of antimicrobial prescribing [4, 7, 14], very
little data exists mapping the clinicians decision pathway
for the management of infections and antimicrobial pre-
scribing within secondary care. A greater understanding
of the decision pathways taken by prescribers may allow
for the development of targeted interventions for spe-
cific aspects of this pathway.
We report a study to map the decision-making process
of medical physicians in secondary care for acute infec-
tion management and investigate the factors that may
hinder or facilitate the effective use of antimicrobials.
Method
Participant recruitment
The sampling frame for this study included all non-
infection specialist medical physicians (defined as either
(1) clinical specialties who practiced general internal
medicine, such as cardiology, respiratory, and geriatric
medicine, or (2) augmented care specialties such as
haematology and nephrology) who were, at the time of
the study, practicing at Imperial College NHS Healthcare
Trust. The Trust comprises of three separate hospitals
(1500 beds) that serve a population of 2.5 million
citizens. Medical physicians from those in training (i.e.
on rotation and specialist trainees) to consultant grade
were included. Given that the majority of UK antimicro-
bial prescribing is performed by physicians, we elected
to exclude other healthcare professionals involved in
infection management (e.g. pharmacists and nurses). Pri-
mary care physicians, surgeons, intensive care specialists
and focused specialties, such as psychiatry, were ex-
cluded from this study as the focus was the management
of acute infections in the medical specialty, outside of
highly specialised settings. Furthermore, many specialist
areas excluded tend to also engage in a broader range of
antimicrobial prescribing activities (e.g. prophylactic
therapy in surgery) and also often rely on support
through multi-disciplinary management of infections
with medical and/or infection team input, which has
been demonstrated to improve patient outcomes for in-
fection management in these settings [15–21].
Using purposive sampling, physicians were invited to
participate in this study [22, 23]. The aim of this study
was to map out and compare the decision-making pro-
cesses employed for acute infection management on the
hospital wards by non-infection medical specialties and
explore any factors that influenced this process. Partici-
pants were purposively sampled at different levels of
training (on-rotation, specialist trainee and consultant)
with deliberate selection that aimed to reflect the
diversity of medical specialties within the hospital envir-
onment. To achieve this, physicians in the 11 major
non-infection medical specialties within the hospitals,
who are responsible for in-patients, were contacted via
email and invited to participate in face-to-face semi-
structured interviews. Two follow-up emails were sent if
there was no reply from the initial invitation email at
weekly intervals. Respondents who accepted to partici-
pate via email were stratified into on-rotation, specialist
trainee and consultant physicians for interviews. All par-
ticipants consented to participating in the study and
have their interviews recorded. Interviews were con-
ducted between August 2015 and April 2016, by one re-
searcher (TMR; a junior doctor/clinical researcher not
working within the hospitals in question). A standar-
dised, piloted 10-question semi-structured interview
guide (Appendix) was initially used to structure the in-
terviews. Participants from each of the specialties and
grades of clinician were interviewed [22–24]. Interviews
were continued for each stratified grade and specialty
until saturation was reached and no new themes were
found to emerge [22, 23, 25, 26]. All data were anon-
ymised with only the interviewer knowing participant
identities. The interviews were audio recorded and then
transcribed verbatim.
The study protocol was reviewed by the West London
Regional Ethics Committee and considered to meet
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criteria for monitoring under service evaluation governance
structures (REC 15/LO/1269/ICHNT Service Evaluation
SE113).
Data analysis
A grounded theory approach was applied to data ana-
lysis [22, 23]. NVIVO Pro 11.0 software was used to sup-
port analysis of the transcripts with the same researcher
(TMR) reviewing all transcripts and performing initial
line-by-line coding. During analysis, emerging themes
and theories were discussed with a multi-professional
team of researchers including non-medical researchers
(BH, PH, PG), physicians (LSPM, AH), nurses (ECS),
pharmacists (EC) and social science researchers (ECS,
EC) to increase reflexivity and allow the main reviewer
to be more aware of their own perceptions [27]. Deviant
statements that may contradict emerging themes were
also actively sought out to improve the rigor of our ana-
lysis [25, 28].
Results
Thirty four physicians from 10 non-infection medical
specialties responded to the invitation email agreeing to
participate in the study. However, saturation was
reached after 20 interviews. Seven participants were on-
rotation physicians (from newly qualified to fourth year
in training), four were specialist trainees, and nine were
consultant level (Table 1). The interviews ranged in dur-
ation from 12 to 32 minutes, with a median length of
20 minutes.
Mapping the decision making process
Analysis of the data identified six common themes de-
scribing the stages of the decision-making process for in-
fection management. Clinicians reported that they begin
with a predefined risk of an infection being present and
then systematically add further information in a stepwise
process, allowing optimisation of decisions on diagnosis
and management in a dynamic manner. Although this
process could also be viewed as a cyclical process, with
physicians returning to step 1 every time they re-assess
the patient, the steps and common variables considered
within each step by the individual physician have been
mapped out in a linear fashion for simplicity in Fig. 1.
The antibiotic decision-making process begins by
looking for changes in the patient’s physiological param-
eters, with temperature being an important factor
assessed at this point. Following this, participants report
that the second stage involves attempting to localise and
confirm that infection is present. This was reported to
involve both searching for reported symptoms and back-
ing this up with signs on examination. The third step re-
ported as part of this process was the review and planning
of further investigations, with C-reactive protein regarded
as a key biological indicator of infection during this phase
of management. Fourthly, through comparison and syn-
thesis of findings from steps one to three, physicians re-
ported that this allows them to construct a picture of the
severity of the infection that they are managing. This was
widely reported to be judged based on the overall ‘clinical
picture’ that is built up during steps one to three with jun-
ior physicians also tending to report using criteria such as
the ‘septic six’ or ‘Systemic Inflammatory Response Syn-
drome criteria’ to help determine the severity and whether
or not this is classified as sepsis. The fifth reported step in
the pathway is the decision of initiating antimicrobial
treatment. The local microbiology guidance (written or
electronic) provided within the hospitals involved was a
key factor determining what therapy would be com-
menced, with physicians describing how steps one to four
determine how this information is interpreted. Deferring
therapy (or ‘watch and wait’) was an option also consid-
ered by the participants. The final step in the pathway was
the review and refinement stage, which can occur through
two separate or overlapping routes. The first of these is in-
ternally, with the individual physician returning to the first
stage of the decision pathway and assessing for changes in
Table 1 Characteristics of medical physician participants
interviewed from Imperial College Healthcare NHS Trust about
their approach to infection management within secondary care
Grade Specialty
Consultant Acute Medicine
Consultant Acute Medicine/Endocrinology
Consultant Haematology
Consultant Haematology
Consultant Haematology
Consultant Care of the Elderly
Consultant Gastroenterology/Acute Medicine
Consultant Respiratory Medicine
Consultant Respiratory Medicine
Specialist Registrar Care of the Elderly
Specialist Registrar Care of the Elderly
Specialist Registrar Cardiology
Specialist Registrar Clinical Pharmacology
& Therapeutics/General Medicine
Core Trainee Year 2 On rotation - Acute Medicine
Core Trainee Year 1 On rotation - Acute Medicine/
Stroke Medicine
Foundation Year 2 On rotation - Gastroenterology
Foundation Year 2 On rotation - Respiratory Medicine/
General Medicine
Foundation Year 2 On rotation - Acute Medicine
Foundation Year 1 On rotation - Renal Medicine
Foundation Year 1 On rotation - Acute Medicine
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each stage over time, building on the information ob-
served during their initial review. The second route is by
external review, by another physician (often reported as
more senior or specialist), who uses stages one to five to
review and refine the management decision made by the
prescriber (Table 2).
Factors influencing the decision-making process
There were several key themes that emerged from the
participant interviews to describe factors that influence
the decision-making process outlined above. Two of
these were common themes that have previously been
reported in the literature; hierarchical team systems and
etiquette around prescribing practices [7, 29, 30]. Several
previously unreported concepts were also identified
within this study surrounding stopping/de-escalating
therapy, the role of guidelines and microbiology advice,
and feelings of responsibility for providing optimal care.
Many of these factors tended to largely influence the lat-
ter half of the decision pathway, surrounding initiation
and review of antimicrobial therapy.
Physician skills used to assess the patient
Participants described the feeling of overall responsibility
of the team and, in particular, the consultant for the
patient under their care. This level of responsibility was
reported to drive consultants to make autonomous deci-
sions about the management of their own patients, using
previous experiences and knowledge to make subjective
assessments of the state of their patient using the path-
way described in Fig. 1. Whilst junior members of the
team may make initial decisions about the management
of patients, the consultant reported seeing themselves as
the final decision maker, with their job to review and re-
fine the decisions of junior colleagues.
This perception projects down the medical team, with
specific expectations made about junior colleagues’ ac-
tions, especially those on-rotation. On-rotation doctors
report that they develop their assessment and decision-
making skills through clinical practice. They are usually
the first individuals to respond to an unwell patient, and
tend towards reliance on objective parameters, such as
heart rate and temperature in the place of subjective
measures such as examination findings and general im-
pression of the patient, which take more predominance
when consultants make their assessment. Furthermore,
on-rotation doctors report fears of missing the septic pa-
tient. It appears that this fear of sepsis, linked with the
expectation placed on juniors to prescribe antibiotics,
can often lead to inappropriate views of infection man-
agement, in particular antimicrobial prescribing. This
often culminates in there being an overwhelming need
to commence antimicrobials as soon as possible in any-
one suspected of having an infection.
Antibiotic prescribing as a key component of provision of
optimal care
Another reported factor that influences the provision of
optimal care is the fact that the patient is in hospital,
which promotes the physician to need to feel they are
providing optimal care for their patient regardless of
whether this is evidence based or not. A theme that
emerged was that physician definitions of optimal care
includes the prescription of antibiotics, with intravenous
often felt to be more optimal than oral for those requir-
ing treatment in hospital (Table 3).
Ambiguity in stopping/de-escalating antibiotic therapy
Whilst junior physicians have a huge weight of expect-
ation to start antibiotics as quickly as possible in patients
Fig. 1 Reported individual decision pathway of infection management for medical physicians within secondary care
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suspected of having infection, the opposite appears true
of them stopping or de-escalating therapy. A key factor
throughout the interviews was that on-rotation doctors
are not expected to stop or de-escalate therapy, with this
responsibility seen as something only consultants and
specialist registrar trainees undertake. Furthermore, it
was widely reported by junior physicians that there is
often variable feedback on the decisions that they have
made following review and refinement by an external re-
viewer. This caused a great deal of frustration with jun-
ior prescribers, who often did not fully appreciate why
their decisions had been over-ruled/changed and there-
fore feel that they do not develop a deep understanding
of this skill. Another area of frustration reported by jun-
ior doctors was the heterogeneity between senior clini-
cians to how they approach stopping or de-escalating
therapy, which when teamed with lack of feedback can
often deter trainees from even attempting to make or
suggest changes to therapy in this respect. This is some-
thing that was supported by senior participants, who
reflected on the lack of an evidence base for lengths of
treatment to support them acting as senior decision-
makers (Table 4).
The role of guidelines and microbiology advice
Antimicrobial prescribing guidelines and clinical micro-
biology services play a large role in the decision-making
process for infection management, despite senior physi-
cians taking responsibility for the patients’ overall man-
agement and care. On-rotation and specialist trainee
physicians report adherence to guidelines for prescribing
as they realise that this is the expectation of their senior
colleagues and the hospital. Consultants report that their
job is to ensure that these guidelines are adhered to
when this is appropriate, but also retain autonomy to be
able to adapt guidelines based on their own experience
and feel for the situation.
For on-rotation and specialist trainee physicians,
microbiology services and advice is seen as a very valu-
able and convenient point of access, often referred to as
a safety-net for challenging decisions, which are not ne-
cessarily outlined in the local antimicrobial guidelines or
when a junior physician is not confident that they have
selected the correct treatment. It is at this point that
physicians tend to “just call microbiology and ask….”.
However, several issues with the reliance on microbiol-
ogy services for helping the decision-making process are
Table 2 Thematic construction of medical physicians’ decision pathway for the management of acute infections in secondary care
No. Theme Supporting quotation
1 Bayesian process “It’s like Bayesian model where you refine your likelihood of diagnoses based on every new quantum of
information you get, so you start off with the physiological parameters, then your differential is refined based on
blood results and further refined based on the microbiology.” [Specialist Trainee, clinical pharmacology &
therapeutics]
2 Physiological parameters “So the first thing I do is look at the vital signs and basically make sure that the patient is haemodynamically
stable” [Consultant, acute medicine]
“Bearing in mind that most patients have a multitude of different things going on and it could be an infection
or it could be many other things, the temperature would be the first thing you would look at” [Consultant,
gastroenterology/acute medicine]
3 Localise/confirm infection “So basically history and then examine them [the patient], and then reaching a diagnosis” [On-rotation, acute
medicine/stroke]
“Access the patient clinically if I suspect infection and then I would try to determine where the infection is
coming from” [Consultant, acute medicine/endocrinology]
4 Investigations “Determine where the infection is coming from, where the source is and take appropriate cultures and do further
investigations as indicated” [Consultant, acute medicine/endocrinology]
“The other secondary tests, such as inflammatory markers, give us an idea of whether there really is sepsis or
whether there is some other pathology” [Consultant, respiratory 1]
5 Determine severity “I would still want to be assessing the severity and particularly looking for evidence of sepsis” [Consultant,
respiratory 2]
“If someone is clinically well and may have an infection I probably would rather wait because they may not
need antibiotics at all. It could be a viral infection. So it very much depends on the clinical picture and medical
context” [Consultant, acute medicine/endocrinology]
6 Initiate treatment “We use local policy guidelines, so when I am assessing a patient I am thinking – Okay where is the focus? And
also, if I know where it is [the focus], what antibiotics specifically does my hospital use?” [On-rotation,
respiratory/general medicine]
“I think if it isn’t clearly in the guideline or I am not sure, if it doesn’t easily fit into the guideline, I am going to
say [to my juniors], okay speak to microbiology and see what they think” [Consultant, respiratory 1]
7 Review & refine “Look at the patient and make sure that they are getting better, the temperature is resolving, and their clinical
symptoms and signs are improving” [Consultant, acute medicine]
“Whoever has [initially] seen the patient will make the initial decision on differential diagnosis and required
treatment. Thereafter, it will be the consultant review who will say yes I agree or not, and does the treatment
also adhere to Trust policy? So it is very algorithmic” [Consultant, acute medicine/endocrinology]
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also reported by senior physicians. These include poor
communication pathways during microbiology discus-
sions, the lack of microbiologist responsibility for out-
comes of therapy recommended and a lack of continuity
in the service provided due to rotation of trainee physi-
cians. Furthermore, this perceived lack of responsibility re-
ported means that consultants report that they are often
reluctant to change decisions based on the advice of junior
colleagues from other specialties, such as microbiology,
especially when it is perceived that they are not fully aware
of all the patient factors outlined in the decision process
(Table 5).
Discussion
Medical physicians report a common stepwise approach
to the decision process surrounding acute infection
management, where new information is constantly con-
sidered in the context of prior knowledge in a dynamic
and often multi-level Bayesian-like process. Despite a
common overall approach, a number of factors alter the
Table 3 Selected quotes surrounding participants experiences and expectations of prescribing antibiotics
No. Quote
Expectations of antimicrobial use
1 “I think I know when would be an easy enough time as a junior doctor to go, yeah, I think this warrants
Tazocin, this warrants cefuroxime IV. So for some drugs I think you have a little bit more of an ease of
prescribing because you’re not too worried about the downsides”
On-rotation, acute medicine 1
2 “So nights, I think obviously it becomes much more of a zoo doesn’t it really, so people tend to start
broad spectrum agents without really looking through previous microbes and patients have a tendency to
stay on that till it’s reviewed in daytime hours”
On-rotation, acute medicine 2
3 “If the patient is septic or something, you have to start antibiotics within your hour, Sepsis Six, but then
you’re also under pressure to get the right source”
On-rotation, acute medicine 2
4 “Yeah, definitely in terms of how you go but I think anyone who’s done hospital medicine now sees that
Tazocin is basically the port of call for most things”
On-rotation, cardiology
5 “When I look back at years gone past, I think I was probably quite gung-ho with antibiotics because it
was the easy option because you didn’t want to get in trouble and I’m sure plenty of patients in
[region - UK] got BenPen [benzylpenicillin] and Cipro [ciprofloxacin] when they might have lived without
it. But this is a situation in which, I think, the way I’ve changed is that I tend to look at what the risks of
deferring here versus not”
Specialist registrar, cardiology
6 “I’ve got a bit of a nice cushion from all the senior levels about even if I prescribe the wrong antibiotic, I
don’t mean of course prescribing penicillin when someone’s penicillin allergic, that’s not what I mean. I
mean prescribing for example flucloxacillin when it’s an E. coli bacteria, wrong bacteria, wrong antibiotic
of choice or bacteria, but an antibiotic nonetheless”
On-rotation, acute medicine 3
7 “I think a lot of people, myself included, would say if you are admitting the patient to hospital and they
have an infection severe enough to come into hospital then you should, and I know this is not what
microbiologists would say, but in my mind you like to feel like you are doing something that they couldn’t
have at home and that’s why you give them some intravenous antibiotics when they come into hospital
with a view to stepping them down very quickly afterwards, and I think it makes everyone feel better
whether it’s the patient and more significantly the doctor”
Consultant, general internal medicine
8 “I would not expect an SHO [senior house officer] to decline to give antibiotics” Specialist registrar, geriatrics
Table 4 Selected quotes surrounding participants experiences and expectations of de-escalating/stopping antibiotics
Expectations around stopping/de-escalating therapy
1 “We are responsible for everything on the ward as well as all the decisions and I think we’ve got these practices
in place which make sure that the antibiotics are stopped at a particular time when they needed to be stopped”
Consultant, haematology
2 “I’m complete disempowered [to stop antibiotics], completely because they’re so complicated and the consultants
who know their patients have their own ways of prescribing. It’s very unusual that anyone would actually explain
to you what they’re thinking. I think I’ve had one explanation which was like a ray of sunshine”
On-rotation, renal
3 “In terms of stopping antibiotics yeah, I think stopping antibiotics is a very nebulous thing in itself… it is pretty
random and is not really a huge amount of evidence out there.... I feel very happy with making decisions as to
whether to stop after three times, seven, ten days whatever. I don’t think that’s a big issue”
Consultant, general medicine
4 “So I feel quite, I wouldn’t say disempowered, but I feel like the seniors make most of the decisions. So I’m quite
reluctant to make any decisions about [de-escalating] antibiotics”
On-rotation, gastroenterology
5 “Stopping them is generally, from my experience, has been a senior’s [decision]” On-rotation, acute medicine 1
6 “De-escalating can be a little bit more tricky, it’s very much individually based. [For] some people it’s easier but
if there’s no plan in place, if someone hasn’t said for five days, go for IVs and then deescalate to PO I would
be hesitant. I would tend to want to get a little bit of reassurance”
On-rotation, acute medicine 2
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weighting given to individual variables in this process,
many of which focus on the later phases of the decision
process (initiation of therapy and reviewing/refining those
decisions). Factors that significantly influence this are ex-
pectations of providing optimal care for the patient, per-
ceptions surrounding stopping and de-escalating therapy,
and interactions with local guidelines and microbiology
advice provided by specialists. Previously reported factors
of team hierarchies and prescribing etiquette, also featured
heavily [7, 29, 30]. Prescribing etiquette refers to the un-
written social code of practice around antibiotic prescrib-
ing which includes the desire for clinical autonomy and
the reluctance to interfere with the antibiotic prescribing
behaviours of peers [7].
Windows of influence on decision making
There are four defined spheres of influence that affect
physician-reported decision-making in the infection
pathway. These could be thematically identified as either
consciously or subconsciously influencing the non-
infection specialist medical physician’s decision process
for acute infection management. These are (1) implicit
factors (such as the stages reported in Fig. 1), which are
known to both the individual and the wider team and
are what are commonly incorporated into guidelines and
protocols for antimicrobial use such as the ‘start-smart-
and-focus’ campaign within the UK [31]; (2) explicit fac-
tors, which are often blind spots that the individual often
is not aware of but may be appreciated by others, such
Table 5 Selection of participant quotes surrounding their antimicrobial guidelines, clinical microbiology services and some problems
associated with information provided by these sources
No. Quote
Reliance on guidelines
1 “Does that really change your management? With the majority of cases it hasn’t. So you strap them on the
standard hospital protocol for CAP/infective exacerbation and you tend to just carry it on”
On-rotation, acute medicine 1
2 “Well because we’re almost held down now by [antibiotic app guidelines] or whatever your Trust uses, so
you end up, if you haven’t done something by that choice you will go, or normally a pharmacist will go,
why haven’t you done that?”
On-rotation, acute medicine 2
3 “I do find antibiotic guidelines very helpful, and actually in the last couple of trusts I’ve worked in, they’ve
been so comprehensive that I’ve not really used any other sources at all”
Specialist registrar, geriatrics
4 “I think in terms of decision making I have to say I don’t keep up to date with the antibiotic formula because
I look it up if I need it”
Specialist registrar, cardiology
5 “Quite often on a post-take ward round say, why are we giving this, has anyone checked the policy, is this
in line with policy because I don’t think it is?”
Consultant, respiratory
Reliance on microbiology
1 “If I think it clearly isn’t within guideline or I’m not sure, it doesn’t easily fit into the guideline I’m going to say,
speak to micro”
Consultant, respiratory
2 “I think when you call the microbiologist the fact that you’ve made the call has already told them that
you’re concerned so you’re almost saying, I want a change, give me further guidance”
Consultant, geriatrics
3 “If the patient has a lot of allergies for example, then that often makes it more difficult and I often end up
speaking to micro if that’s the case”
On-rotation, respiratory
Problems with guidelines and microbiology
1 “I mean I’m a complete pedant I hate this idea that microbiologists have just given antibiotics broad
spectrum for sepsis of unknown origin because that’s not what I’m about as a physician”
Consultant, gastroenterology
2 “I think the difficult thing which sometimes arises that microbiology are often the more conservative end of
the antibiotic spectrum and say, OK, you’ve had your course, stop and I may agree with that as a registrar.
But the problem is that actually suggesting for me to do it is the wrong person because it’s my decision once
I’ve seen the patient on the ward round, but once you’ve got a consultant [microbilogist] that’s come and
ratified the decision then that becomes their decision”
Specialist registrar, cardiology
3 “They tend to give more of a patient specific approach but the difficulty in that is that they haven’t seen
the patient. So they’re sort of just giving you advice over the telephone”
On-rotation, gastroenterology
4 “A lot of the time is I would maybe rather wait and speak to someone whose opinion and knowledge seems
more valuable, where sometimes maybe the opinion that you get out of hours [from junior microbiologists]
is someone who is just answering a question to get it dealt with, and so it’s too broad, it’s too much”
Consultant, respiratory
5 “Well it’s not patient specific [local guidelines] so it’s quite generalised and it won’t always have all the
information about the patient”
On-rotation, respiratory
6 “I always think that people and especially microbiologists recommend changing antibiotics far too soon. You ring
up a micro registrar who just says, oh immediately I want to change from Augmentin to Tazocin. Well, why?”
Consultant, gastroenterology
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as observations of team hierarchies and prescribing eti-
quette; (3) internalised rationale (or hidden reasoning),
that is known to the individual but often not externalised to
others, such as is reported about senior decision-makers
who do not feedback rationale for changing therapy to
more junior colleagues (this can often cause confusion and
frustration when reasons for decisions are not shared
beyond the individual who has made them); and (4)
subconscious influences that are neither identified by
the individual or wider cohort, but are likely to play a
significant role in the decision-making process. This
could potentially include the role of other disciplines
such as pharmacists and nursing staff who have been
demonstrated to have a role in promoting optimal use
of antimicrobials in several settings [32, 33], but were
seldom reported and not identified by the participants
in this study. This is especially grave, given that the role
of the pharmacist, in the UK, is often described as the
corner stone of antimicrobial stewardship (AMS) inter-
ventions and further highlights the need to challenge
the current prescriber hierarchies that exist within the
hospital setting [32, 34]. What could be observed from
physician interviews was that a major factor for the en-
gagement of pharmacists in the decision process appeared
to be their level of seniority and presence and involvement
in the core medical team caring for the patient.
“And the pharmacists are often good, I think when we
often have the pharmacists on the post-take ward round
and it depends a bit on their seniority and confidence,
so the ones who will speak up and challenge are
excellent” [Consultant, respiratory]
Therefore, interventions may also benefit from target-
ing the promotion of multi-professional integration to
help normalise the role of the pharmacist and other
healthcare professionals within the decision-making process
surrounding infection management.
Despite there being several windows of influence that
appear to contribute to the decision-making process,
current interventions that include quality improvement
and guidelines/policy appear to only focus on the initial
implicit factors identified. Broader approaches to address
the wider social and cultural knowns and unknowns
must also be considered if we are to have a significant
impact on the non-expert prescriber’s decision pathway.
This is especially important as AMR is now a major driver
of the patient safety and political agenda. With this, the
role of behavioural sciences in promoting the appropriate
and judicious use of antimicrobial agents has become a
leading theme for AMS interventions [8, 34, 35]. The role
of team dynamics and hierarchy has been explored in the
intensive care unit and also considered for translation into
clinical decision support software [30, 36–38]. However,
our study has highlighted that simply understanding the
decision process and incorporating it into AMS interven-
tions is unlikely to be successful given the complex factors
that influence decision making at all levels of the physician
hierarchy.
Distributing responsibility for decision making
A major theme emerging from this study was that of re-
sponsibility for the decisions that are made for the pa-
tient. This was highlighted when consultants considered
clinical microbiology advice. Whilst the role of clinical
microbiology was seen as a great help overall, senior cli-
nicians often see the quality of the advisory services to
be dependent on the information that is provided by
junior colleagues, the lack of continuity in who they gain
advice from, and the limited responsibility for the conse-
quences of therapy that the microbiologist has when
they provide advice. This links with the senior clinicians’
experience and autonomy in decision-making, which
often leads to frustration and consideration of alternative
treatments that may not be based on evidence. There-
fore, it would seem that, to effectively address these per-
ceived issues, some level of responsibility for the impact
of prescribing decisions must be distributed beyond that
of the senior consultant in charge of the patient.
Addressing the role of antibiotics in providing optimal
care
Physicians report reflective practices as they progress
through their training. They report developing an under-
standing, that as junior trainees, they were scared of sepsis
or under treating an individual and therefore causing harm.
As a response to this concern, they focus solely on the short
term, preferring to prescribe broad-spectrum agents and
seek senior physician support to refine these decisions. This
decision process is further supported by the provision of
detailed local prescribing guidelines, which provide junior
trainee’s with justification for making prescribing decisions
and protecting them from judgement by their senior team
members, even if those decisions are incorrect. This is fur-
ther reinforced by the expectation placed upon them to be
able to prescribe antibiotics for infections. The opposite is
true of stopping or de-escalating antimicrobials, which is
seen as a more serious decision that could affect the patient
negatively and is therefore deferred to the senior decision-
makers. To effectively promote improvements in anti-
microbial use in secondary care these assumptions must be
effectively challenged to address the negative aspects of
antimicrobial therapy and empower individuals in revising
the decisions that they have made.
Limitations
This study had several limitations. Firstly, we only inter-
viewed medical physicians working in a narrow number of
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specialties from one UK NHS hospital Trust, meaning
that there may be variations in the team dynamics and
workflows in different specialties (such as surgery) and re-
gions of the world. Furthermore, the researcher, a junior
medical doctor, performed all of the interviews (TMR),
which was considered as a potential source of bias during
the interview and analysis process. To address this during
data analysis, a multi-professional group of researches in-
volving doctors (LSPM, AH), a pharmacist (EC), a nurse
(ECS), and lay researchers (BH, PH, PG) all reviewed the
data and provided input on final thematic selection. Fi-
nally, although our theoretical sampling methodology
followed validated guidelines and we purposefully sought
out deviant statements to contradict emerging themes,
the reliance on individual responses to invited emails may
have introduced selection bias as individuals interested in
antimicrobial prescribing and stewardship may have been
more likely to respond to invitations [25, 28].
Conclusion
In conclusion, we have identified that physicians in sec-
ondary care adopt a Bayesian approach to the decision
process for infection management. Whilst a large num-
ber of factors influence how physicians weight individual
variables, there is also a common theme, which must be
addressed if behaviour change interventions promoting
optimised antimicrobial prescribing are to be successful.
These include distribution of the responsibility of pre-
scribing decision, fostering an earlier understanding of
the risks of antimicrobial therapy and expectations about
de-escalation, and promotion of true multi-professional
involvement in decision-making for infection manage-
ment. Future studies must look to quantify the influence
of identified variables on the decision-making pathway.
Furthermore, reported decision-making pathways must
be linked with observations from clinical practice to
allow triangulation of reported findings and identifica-
tion of further areas for targeted interventions to pro-
mote the optimal management of acute infections within
secondary care.
Appendix
Baseline questions used for decision mapping interviews
1. For a patient with an infection, describe how
investigation and management decisions (including
prescribing antimicrobials) are made.
2. If you had to rank (i) patient physiology, (ii) biomarker
changes and (iii) microbiology results in their
importance in relation to antimicrobial prescribing,
how would you do so?
Prompts: how do these three factors relate to: sending fur-
ther tests? If so which? Starting antimicrobials/narrowing
spectrum of antimicrobials/stopping antimicrobials?
3. How is the final decision on infection management
made?
How are these decisions made out of hours at night? And
at the weekend?
4. Do you have a vision of an ideal way for infection
management decisions to be made?
5. Are there any barriers to you making what you
think are the optimal antimicrobial decisions?
6. Are there any aids that help with making the
optimal antimicrobial decisions?
7. How do you access patient data when you are
making infection management decisions?
8. How do you access published medical literature to
help make decisions?
9. When do you access published medical information
to help make decisions?
10.Do you feel empowered or dis-empowered to make
decisions to start, stop or change antimicrobial
prescriptions?
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